Molecular Mechanisms of Muscle Fatigue

Muscle fatigue (MF) declines the capacity of muscles to complete a task over time at a constant load. MF is usually short-lasting, reversible, and is experienced as a feeling of tiredness or lack of energy. The leading causes of short-lasting fatigue are related to overtraining, undertraining/decond...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dumitru Constantin-Teodosiu, Despina Constantin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/2cf70f3afb8644a5a7aab84b98cafc39
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2cf70f3afb8644a5a7aab84b98cafc39
record_format dspace
spelling oai:doaj.org-article:2cf70f3afb8644a5a7aab84b98cafc392021-11-11T17:04:10ZMolecular Mechanisms of Muscle Fatigue10.3390/ijms2221115871422-00671661-6596https://doaj.org/article/2cf70f3afb8644a5a7aab84b98cafc392021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11587https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Muscle fatigue (MF) declines the capacity of muscles to complete a task over time at a constant load. MF is usually short-lasting, reversible, and is experienced as a feeling of tiredness or lack of energy. The leading causes of short-lasting fatigue are related to overtraining, undertraining/deconditioning, or physical injury. Conversely, MF can be persistent and more serious when associated with pathological states or following chronic exposure to certain medication or toxic composites. In conjunction with chronic fatigue, the muscle feels floppy, and the force generated by muscles is always low, causing the individual to feel frail constantly. The leading cause underpinning the development of chronic fatigue is related to muscle wasting mediated by aging, immobilization, insulin resistance (through high-fat dietary intake or pharmacologically mediated Peroxisome Proliferator-Activated Receptor (PPAR) agonism), diseases associated with systemic inflammation (arthritis, sepsis, infections, trauma, cardiovascular and respiratory disorders (heart failure, chronic obstructive pulmonary disease (COPD))), chronic kidney failure, muscle dystrophies, muscle myopathies, multiple sclerosis, and, more recently, coronavirus disease 2019 (COVID-19). The primary outcome of displaying chronic muscle fatigue is a poor quality of life. This type of fatigue represents a significant daily challenge for those affected and for the national health authorities through the financial burden attached to patient support. Although the origin of chronic fatigue is multifactorial, the MF in illness conditions is intrinsically linked to the occurrence of muscle loss. The sequence of events leading to chronic fatigue can be schematically denoted as: trigger (genetic or pathological) -> molecular outcome within the muscle cell -> muscle wasting -> loss of muscle function -> occurrence of chronic muscle fatigue. The present review will only highlight and discuss current knowledge on the molecular mechanisms that contribute to the upregulation of muscle wasting, thereby helping us understand how we could prevent or treat this debilitating condition.Dumitru Constantin-TeodosiuDespina ConstantinMDPI AGarticleskeletal muscleatrophymuscle functionfatigueBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11587, p 11587 (2021)
institution DOAJ
collection DOAJ
language EN
topic skeletal muscle
atrophy
muscle function
fatigue
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle skeletal muscle
atrophy
muscle function
fatigue
Biology (General)
QH301-705.5
Chemistry
QD1-999
Dumitru Constantin-Teodosiu
Despina Constantin
Molecular Mechanisms of Muscle Fatigue
description Muscle fatigue (MF) declines the capacity of muscles to complete a task over time at a constant load. MF is usually short-lasting, reversible, and is experienced as a feeling of tiredness or lack of energy. The leading causes of short-lasting fatigue are related to overtraining, undertraining/deconditioning, or physical injury. Conversely, MF can be persistent and more serious when associated with pathological states or following chronic exposure to certain medication or toxic composites. In conjunction with chronic fatigue, the muscle feels floppy, and the force generated by muscles is always low, causing the individual to feel frail constantly. The leading cause underpinning the development of chronic fatigue is related to muscle wasting mediated by aging, immobilization, insulin resistance (through high-fat dietary intake or pharmacologically mediated Peroxisome Proliferator-Activated Receptor (PPAR) agonism), diseases associated with systemic inflammation (arthritis, sepsis, infections, trauma, cardiovascular and respiratory disorders (heart failure, chronic obstructive pulmonary disease (COPD))), chronic kidney failure, muscle dystrophies, muscle myopathies, multiple sclerosis, and, more recently, coronavirus disease 2019 (COVID-19). The primary outcome of displaying chronic muscle fatigue is a poor quality of life. This type of fatigue represents a significant daily challenge for those affected and for the national health authorities through the financial burden attached to patient support. Although the origin of chronic fatigue is multifactorial, the MF in illness conditions is intrinsically linked to the occurrence of muscle loss. The sequence of events leading to chronic fatigue can be schematically denoted as: trigger (genetic or pathological) -> molecular outcome within the muscle cell -> muscle wasting -> loss of muscle function -> occurrence of chronic muscle fatigue. The present review will only highlight and discuss current knowledge on the molecular mechanisms that contribute to the upregulation of muscle wasting, thereby helping us understand how we could prevent or treat this debilitating condition.
format article
author Dumitru Constantin-Teodosiu
Despina Constantin
author_facet Dumitru Constantin-Teodosiu
Despina Constantin
author_sort Dumitru Constantin-Teodosiu
title Molecular Mechanisms of Muscle Fatigue
title_short Molecular Mechanisms of Muscle Fatigue
title_full Molecular Mechanisms of Muscle Fatigue
title_fullStr Molecular Mechanisms of Muscle Fatigue
title_full_unstemmed Molecular Mechanisms of Muscle Fatigue
title_sort molecular mechanisms of muscle fatigue
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/2cf70f3afb8644a5a7aab84b98cafc39
work_keys_str_mv AT dumitruconstantinteodosiu molecularmechanismsofmusclefatigue
AT despinaconstantin molecularmechanismsofmusclefatigue
_version_ 1718432167306985472